A phase 3 clinical trial published in @TheLancet found that proton beam therapy may offer longer survival and fewer side effects for people with oropharyngeal cancer. Mayo Clinic investigators, including Daniel Ma, M.D., and Nadia Laack, M.D., helped lead the study. Results https://t.co/d13lrII5wC